Back
The Chemours Quote, Financials, Valuation and Earnings
Sponsored
CC
Sponsored
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Buy
53
CC
The Chemours
Last Price:
25.99
Seasonality Move:
7.64%
7 Day Trial
ALL ACCESS PASS
$
7
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to SeeThe Chemours Price Quote
$25.99
-0.01 (-2.84%)
(Updated: May 2, 2024 at 5:29 AM ET)
The Chemours Key Stats
Buy
53
The Chemours (CC)
is a Buy
Day range:
$25.75 - $27.25
52-week range:
$15.10 - $39.05
Dividend yield:
3.85%
P/E ratio:
0.00
P/S ratio:
0.67
P/B ratio:
5.15%
Volume:
2.5M
Avg. volume:
1.5M
1-year change:
-12.63%
Market cap:
$3.9B
Revenue:
$6B
EPS:
$-2.23
How Much Does The Chemours Make?
-
How Much Are The Chemours's Sales Annually?
CC Revenues are $6B -
How Much Profit Does The Chemours's Make A Year?
CC net income is -$238M
Is The Chemours Growing As A Company?
-
What Is The Chemours's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.12% -
What Is The Chemours's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.65%
The Chemours Stock Price Performance
-
Did The Chemours Stock Go Up Last Month?
The Chemours share price went down by -9.53% last month -
Did CC's Share Price Rise Over The Last Year?
CC share price fell by -12.63% over the past 1 year
What Is The Chemours 52-Week High & Low?
-
What Is The Chemours’s 52-Week High Share Price?
The Chemours has traded as high as $39.05 over the past 52 weeks -
What Is The Chemours’s 52-Week Low Share Price?
The Chemours has traded as low as $15.10 over the past 52 weeks
The Chemours Price To Free Cash Flow
-
Is The Chemours Stock Overvalued?
The Chemours is trading at a price to free cash flow ratio of 433.12 -
Is The Chemours Stock Undervalued?
The Chemours EV to Free Cash Flow ratio is 792.92 -
What Is The Chemours’s Price Earnings Growth Ratio?
CC PEG ratio is 0.00 -
Is The Chemours Trading At A Premium To Earnings?
The Chemours EV to EBIT ratio is 0.00
Is It Risky To Buy The Chemours?
-
How Much Debt Does The Chemours Have?
Total long term debt quarterly is $4B -
How Much Cash Does The Chemours Have?
Cash and short term investments quarterly total is $746M -
What Is The Chemours’s Book Value Per Share?
Book value per share is 5.05
Is The Chemours Cash Flow Positive?
-
What Is CC Cash Flow From Operations?
Cash flow from operations (TTM) is $390M -
What Is The Chemours’s Cash Flow From Financing?
Cash flow from financing (TTM) is $186M -
What Is The Chemours’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$233M
The Chemours Return On Invested Capital
-
Is Management Doing A Good Job?
CC return on invested capital is -7.01% -
What Is The Chemours Return On Assets?
ROA measures how assets are converting to revenues and is -4.18% -
What Is CC Return On Equity?
ROE is a measure of profitability and is -38.48%
The Chemours Earnings Date & Stock Price
-
What Is The Chemours's Stock Price Today?
A single share of CC can be purchased today for 26.00 -
What Is The Chemours’s Stock Symbol?
The Chemours trades on the nyse under the ticker symbol: CC -
When Is The Chemours’s Next Earnings Date?
The next quarterly earnings date for The Chemours is scheduled on July 26, 2024 -
When Is CC's next ex-dividend date?
The Chemours's next ex-dividend date is May 14, 2024 -
How To Buy The Chemours Stock?
You can buy The Chemours shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
The Chemours Competitors
-
Who Are The Chemours's Competitors?
Below is a list of companies who compete with The Chemours or are related in some way:
The Chemours Dividend Yield
-
What Is CC Dividend Yield?
The Chemours’s dividend yield currently is 3.85% -
What Is The Chemours’s Payout Ratio?
The Chemours’s payout ratio is -45.15% -
When Did The Chemours Last Pay A Dividend?
The latest dividend pay date is May 2, 2024 -
What Is The Chemours’s Dividend Per Share?
The Chemours pays a dividend of $0.25 per share
The Chemours Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -64.58% | 87.2% |
Revenue: | -12.11% | -4.28% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 6 |
Sell Recommendations: | 0 |
Price Target: | 31.27 |
Upside from Last Price: | 20.27% |